Increase in left ventricular assist device thrombosis [5]

New England Journal of Medicine

Volumn 370, Issue 15, 2014, Pages 1464-

  Hoefer, Daniel ^a   Velik Salchner, Corinna ^a   Antretter, Herwig ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; LACTATE DEHYDROGENASE;

ANTICOAGULANT THERAPY; DEVICE REMOVAL; DEVICE SAFETY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; LETTER; MEDICAL DEVICE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; THROMBOSIS; TREATMENT INDICATION; TREATMENT RESPONSE; BLOOD; HEART ASSIST DEVICE; NOTE;

HEART-ASSIST DEVICES; HUMANS; L-LACTATE DEHYDROGENASE; THROMBOSIS;

EID: 84898763243     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1401768     Document Type: Letter

References (2)

1. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96. (Pubitemid 47347322)
2. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.